These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26160041)

  • 21. Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.
    Futema M; Plagnol V; Li K; Whittall RA; Neil HA; Seed M; ; Bertolini S; Calandra S; Descamps OS; Graham CA; Hegele RA; Karpe F; Durst R; Leitersdorf E; Lench N; Nair DR; Soran H; Van Bockxmeer FM; ; Humphries SE
    J Med Genet; 2014 Aug; 51(8):537-44. PubMed ID: 24987033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic Architecture of Familial Hypercholesterolaemia.
    Sharifi M; Futema M; Nair D; Humphries SE
    Curr Cardiol Rep; 2017 May; 19(5):44. PubMed ID: 28405938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
    Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
    Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
    Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
    Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations.
    Setia N; Saxena R; Arora A; Verma IC
    Atherosclerosis; 2016 Dec; 255():31-36. PubMed ID: 27816806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically Confirmed Familial Hypercholesterolemia in Patients With Acute Coronary Syndrome.
    Amor-Salamanca A; Castillo S; Gonzalez-Vioque E; Dominguez F; Quintana L; Lluís-Ganella C; Escudier JM; Ortega J; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    J Am Coll Cardiol; 2017 Oct; 70(14):1732-1740. PubMed ID: 28958330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetic epidemiology of homozygous familial hypercholesterolemia in the Hokuriku district of Japan.
    Mabuchi H; Nohara A; Noguchi T; Kobayashi J; Kawashiri MA; Tada H; Nakanishi C; Mori M; Yamagishi M; Inazu A; Koizumi J;
    Atherosclerosis; 2011 Feb; 214(2):404-7. PubMed ID: 21146822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
    Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
    J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
    Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
    J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis.
    Di Taranto MD; D'Agostino MN; Fortunato G
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):979-87. PubMed ID: 26165249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
    Futema M; Bourbon M; Williams M; Humphries SE
    Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.
    Abifadel M; Rabès JP; Jambart S; Halaby G; Gannagé-Yared MH; Sarkis A; Beaino G; Varret M; Salem N; Corbani S; Aydénian H; Junien C; Munnich A; Boileau C
    Hum Mutat; 2009 Jul; 30(7):E682-91. PubMed ID: 19319977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polygenic contribution for familial hypercholesterolemia (FH).
    Medeiros AM; Bourbon M
    Curr Opin Lipidol; 2021 Dec; 32(6):392-395. PubMed ID: 34751168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center study.
    Setia N; Movva S; Balakrishnan P; Biji IK; Sawhney JPS; Puri R; Arora A; Puri RD; Saxena R; Mishra S; Apte S; Kulshrestha S; Ramprasad VL; Verma IC
    J Clin Lipidol; 2020; 14(1):35-45. PubMed ID: 32044282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
    Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
    Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease.
    Trinder M; Francis GA; Brunham LR
    JAMA Cardiol; 2020 Apr; 5(4):390-399. PubMed ID: 32049305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular basis of familial hypercholesterolemia-like phenotype heterogeneity].
    Wang LY; Lin J; Liu S; Chen BS
    Yi Chuan Xue Bao; 2005 Jul; 32(7):770-7. PubMed ID: 16078748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sorting the wheat from the chaff in familial hypercholesterolemia.
    Hooper AJ; Watts GF
    Clin Chem; 2015 Jan; 61(1):6-8. PubMed ID: 25391991
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.
    Tada H; Kawashiri MA; Ohtani R; Noguchi T; Nakanishi C; Konno T; Hayashi K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M
    Atherosclerosis; 2011 Dec; 219(2):663-6. PubMed ID: 21872251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance.
    Snozek CL; Lagerstedt SA; Khoo TK; Rubenfire M; Isley WL; Train LJ; Baudhuin LM
    Eur J Hum Genet; 2009 Jan; 17(1):85-90. PubMed ID: 18648394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.